Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022089562 - USE OF INHIBITING GENETICALLY DEFECTIVE HIV VIRUS

Publication Number WO/2022/089562
Publication Date 05.05.2022
International Application No. PCT/CN2021/127270
International Filing Date 29.10.2021
IPC
C07D 471/00 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
A61K 31/55 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
55having seven-membered rings, e.g. azelastine, pentylenetetrazole
A61K 31/4985 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A61P 31/18 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
18for HIV
Applicants
  • 上海拓界生物医药科技有限公司 TUOJIE BIOTECH (SHANGHAI) CO., LTD. [CN]/[CN]
Inventors
  • 王亚娟 WANG, Yajuan
  • 黄晓星 HUANG, Xiaoxing
  • 刘彪 LIU, Biao
  • 祝伟 ZHU, Wei
  • 李正涛 LI, Zhengtao
Agents
  • 北京戈程知识产权代理有限公司 GE CHENG & CO., LTD
Priority Data
202011196367.730.10.2020CN
202110018293.607.01.2021CN
Publication Language Chinese (zh)
Filing Language Chinese (ZH)
Designated States
Title
(EN) USE OF INHIBITING GENETICALLY DEFECTIVE HIV VIRUS
(FR) UTILISATION DE L'INHIBITION DU VIRUS DU VIH GÉNÉTIQUEMENT DÉFECTUEUX
(ZH) 抑制基因缺陷的HIV病毒的用途
Abstract
(EN) The present invention relates to the use of inhibiting genetically defective HIV virus. In particular, provided are an active agent for inhibiting genetically defective HIV virus such as N155H and the use of the active agent for preparing a medicament for treating diseases caused by genetically defective HIV virus such as N155H.
(FR) La présente invention concerne l'utilisation de l'inhibition du virus du VIH génétiquement défectueux. En particulier, l'invention concerne un agent actif pour inhiber un virus du VIH génétiquement défectueux tel que N155H et l'utilisation de l'agent actif pour préparer un médicament pour traiter des maladies provoquées par un virus du VIH génétiquement défectueux tel que N155H.
(ZH) 涉及抑制基因缺陷的HIV病毒的用途。具体而言,提供了用于抑制诸如N155H等基因缺陷的HIV病毒的活性剂,以及该活性剂用于制备治疗选自N155H等基因缺陷的HIV病毒导致的疾病的药物。
Latest bibliographic data on file with the International Bureau